Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • Editorial Manifesto
    • Impact Factor
    • Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Circulation Research Profiles
    • Trainees & Young Investigators
    • Research Around the World
    • News & Views
    • The NHLBI Page
    • Viewpoints
    • Compendia
    • Reviews
    • Recent Review Series
    • Profiles in Cardiovascular Science
    • Leaders in Cardiovascular Science
    • Commentaries on Cutting Edge Science
    • AHA/BCVS Scientific Statements
    • Abstract Supplements
    • Circulation Research Classics
    • In This Issue Archive
    • Anthology of Images
  • Resources
    • Online Submission/Peer Review
    • Why Submit to Circulation Research
    • Instructions for Authors
    • → Article Types
    • → Manuscript Preparation
    • → Submission Tips
    • → Journal Policies
    • Circulation Research Awards
    • Image Gallery
    • Council on Basic Cardiovascular Sciences
    • Customer Service & Ordering Info
    • International Users
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Impact Factor 13.965
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Circulation Research

  • My alerts
  • Sign In
  • Join

  • Impact Factor 13.965
  • Facebook
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • Editorial Manifesto
    • Impact Factor
    • Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Circulation Research Profiles
    • Trainees & Young Investigators
    • Research Around the World
    • News & Views
    • The NHLBI Page
    • Viewpoints
    • Compendia
    • Reviews
    • Recent Review Series
    • Profiles in Cardiovascular Science
    • Leaders in Cardiovascular Science
    • Commentaries on Cutting Edge Science
    • AHA/BCVS Scientific Statements
    • Abstract Supplements
    • Circulation Research Classics
    • In This Issue Archive
    • Anthology of Images
  • Resources
    • Online Submission/Peer Review
    • Why Submit to Circulation Research
    • Instructions for Authors
    • → Article Types
    • → Manuscript Preparation
    • → Submission Tips
    • → Journal Policies
    • Circulation Research Awards
    • Image Gallery
    • Council on Basic Cardiovascular Sciences
    • Customer Service & Ordering Info
    • International Users
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
In This Issue

In This Issue…

Download PDF
https://doi.org/10.1161/RES.0b013e3182aa12b7
Circulation Research. 2013;113:835
Originally published September 12, 2013
  • Article
  • Figures & Tables
  • Info & Metrics

Jump to

  • Article
    • Jmjd3 and Differentiation (p 856)
    • Adrenergic Modulation of Transgenic CaV1.2 Channels (p 871)
    • TERT-MYOCD Rejuvenation of AT-MSCs (p 902)
  • Figures & Tables
  • Info & Metrics
  • eLetters
Loading

Jmjd3 and Differentiation (p 856)

Figure1
  • Download figure
  • Open in new tab
  • Download powerpoint

Histone demethylase Jmjd3 regulates endothelial, mesodermal, and cardiovascular differentiation of embryonic stem cells, report Ohtani et al.

The addition of three methyl groups to lysine 27 of histone H3—or H3K27me3 —is a repressive epigenetic modification that leads to gene silencing. The protein Jmjd3 is a H3K27 demethylase and therefore activates genes that have been suppressed by the modification. Recent evidence has shown that endothelial genes in adult pro-angiogenic cells are suppressed by H3K27me3. This led Ohtani and colleagues to investigate whether Jmjd3 might promote the expression of such genes earlier in development and thus might contribute to cardiovascular lineage commitment. To test the role of Jmjd3, the team created mouse embryonic stem cells that lacked Jmjd3 and examined their differentiation in vitro. They found that mesodermal, endodermal, and cardiomyoctye differentiation were all perturbed, as evinced by dramatically reduced expression of these lineage marker genes. The mesodermal marker genes, Brachyury and Mixl1 also showed an expected increase in H3K27me3 at their promoter regions. Mice generated from these embryonic stem cells died at early stages of embryo development, indicating an important role of this factor in the development of the cardiovascular system.

Adrenergic Modulation of Transgenic CaV1.2 Channels (p 871)

Figure2
  • Download figure
  • Open in new tab
  • Download powerpoint

Yang et al devise a clever transgenic approach for testing calcium channel regulation.

The calcium channel CaV1.2 plays an essential role in excitation-contraction coupling in cardiac muscle cells. Therefore, not surprisingly dysregulation of this channel has been implicated in electrical instabilities, arrhythmias, and even sudden cardiac death. The activity of CaV1.2 is controlled by β-adrenergic signaling, but the underlying mechanism remains incompletely understood. For example, it has been suggested that cleavage of CaV1.2 at alanine residue 1800 is required for β-adrenergic stimulation, and that this cleavage depends on a neighboring peptide motif. It has also been proposed that phosphorylation at serine residue 1700 is essential for β-adrenergic stimulation. But neither of these possibilities has been tested in native cardiomyocytes. Thus, Yang et al developed transgenic mice that expressed inducible, tissue-specific, and dihydropyridine-resistant versions of CaV1.2. Imparting dihydropyridine resistance enabled the investigators to separate transgenic CaV1.2 from the endogenous dihydropyridine-susceptible channel. The transgenic CaV1.2 carried mutations that disrupted either serine 1700 phosphorylation or the putative cleavage site residues. Yet surprisingly cleavage and β-adrenergic stimulation of CaV1.2 occurred as normal. These results highlight the importance of testing CaV1.2 in its native setting, and the new transgenic approach provides an ingenious and effective means to do so.

TERT-MYOCD Rejuvenation of AT-MSCs (p 902)

Figure3
  • Download figure
  • Open in new tab
  • Download powerpoint

Madonna et al rejuvenate mesenchymal stem cells and improve their reparative potential.

Stem cell therapy is a promising approach for promoting the repair of ischemic tissue. However, it is believed that, the proliferative and the reparative capacity of stem cells diminishes with aging. Therefore, finding ways to rejuvenate the flagging potential of stem cells could improve their therapeutic efficacy. Madonna and colleagues now suggest that transducing mesenchymal stem cells (MSCs) with two factors—telomerase reverse transcriptase (TERT) and myocardin—could achieve such rejuvenation and improve the myogenic potential of these stem cells. TERT is an enzyme that maintains the telomeres of chromosomes, which normally shorten with age, while myocardin regulates cardiovascular myogenic development. When both factors were expressed in MSCs via lentiviral expression plasmids, the cells exhibited improved proliferation, survival and myogenesis in vitro. Importantly, when injected into ischemic hind limb muscles of mice, the transduced cells improved arteriogenesis and blood flow to a greater degree than that achieved with non-transduced MSCs. Taken together these results indicate that overexpression of TERT and myocardin could improve the therapeutic potential of MSCs and their efficacy in treating vascular disorders such as myocardial ischemia and peripheral artery disease.

  • © 2013 American Heart Association, Inc.
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Circulation Research
September 13, 2013, Volume 113, Issue 7
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Jmjd3 and Differentiation (p 856)
    • Adrenergic Modulation of Transgenic CaV1.2 Channels (p 871)
    • TERT-MYOCD Rejuvenation of AT-MSCs (p 902)
  • Figures & Tables
  • Info & Metrics

Article Tools

  • Print
  • Citation Tools
    In This Issue…
    Circulation Research. 2013;113:835, originally published September 12, 2013
    https://doi.org/10.1161/RES.0b013e3182aa12b7

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  •  Download Powerpoint
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Circulation Research.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    In This Issue…
    (Your Name) has sent you a message from Circulation Research
    (Your Name) thought you would like to see the Circulation Research web site.
  • Share on Social Media
    In This Issue…
    Circulation Research. 2013;113:835, originally published September 12, 2013
    https://doi.org/10.1161/RES.0b013e3182aa12b7
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Circulation Research

  • About Circulation Research
  • Editorial Board
  • Instructions for Authors
  • Abstract Supplements
  • AHA Statements and Guidelines
  • Permissions
  • Reprints
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
3355 Keswick Rd
Main Bldg 103
Baltimore, MD 21211
CircRes@circresearch.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured